Morgan Stanley Knock-Out SK/ DE000MB1F3C1 /

3/23/2023 8:17:19 PM	Chg.-0.05	Bid8:51:41 PM	Ask8:51:41 PM	Underlying	Strike price	Expiration date	Option type
3.54EUR	-1.39%	3.56 Bid Size: 750	3.68 Ask Size: 2,000	SEB SA	65.1118 -	12/31/2078	Call

GlobeNewswire 1/27/2022 F2 Strategy’s 2022 Outlook Report Shows Cryptocurrency Adoption, Data Aggregation and Operations Aut...

GlobeNewswire 12/22/2021 MicroEJ and Groupe SEB, leader in small domestic appliances, announce their collaboration in the dev...

pressetext 12/16/2021 PTA-News: Zumtobel Group AG: Zumtobel Group secures further long-term financing until 2026

GlobeNewswire 9/16/2021 F2 Strategy Trailblazes WealthTech Space with Record Growth of Outsourced CTO and Consulting Service...

GlobeNewswire 7/12/2021 Arcutis Announces First Patient Enrolled in Phase 3 Clinical Trial of Topical Roflumilast Foam (ARQ-...

GlobeNewswire 4/7/2021 SEB Partners With Quebec Based Gesticonnect to Digitize Benefits for Emerging Businesses in Quebec

GlobeNewswire 12/12/2019 Norsk Hydro: Hydro signs new USD 1,600 million revolving credit facility with margin linked to reduc...

GlobeNewswire 12/10/2019 Orchestra BioMed™ Secures $20 Million Financing Facility from Silicon Valley Bank

GlobeNewswire 12/5/2019 Orchestra BioMed™ to Present at the Innovation in Cardiovascular Interventions Meeting and the CSI F...

GlobeNewswire 10/16/2019 Orchestra BioMed™ Strengthens Management Team with Appointments of Expert Product Development Leader...

GlobeNewswire 8/27/2019 Orchestra BioMed™ Appoints Dennis Donohoe, M.D., Leading Clinical Development Expert, as Chief Medic...

GlobeNewswire 7/10/2019 Orchestra BioMed™ Completes $34 Million Financing to Accelerate Product Pipeline Development and Adv...

GlobeNewswire 6/13/2019 Orchestra BioMed™ Announces Global Strategic Partnership with Terumo Corporation for Development and...

GlobeNewswire 5/21/2019 SEB: Investment Outlook: Reducing our risk level to neutral

GlobeNewswire 5/17/2019 SEB: Changed future outlook among Swedish CFOs - optimism falling

GlobeNewswire 5/8/2019 SEB: Nordic Outlook: Central bank U-turn is re-energising tired growth

GlobeNewswire 4/30/2019 SEB's first quarter 2019 result

GlobeNewswire 4/24/2019 Orchestra BioMed™ Receives FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon...

GlobeNewswire 4/17/2019 Invitation - SEB's results for the first quarter 2019

GlobeNewswire 3/26/2019 SEB's Annual General Meeting 2019

GlobeNewswire 3/5/2019 SEB's annual reporting published

GlobeNewswire 2/22/2019 Changes in the Nomination Committee's proposal to SEB's Annual General Meeting 2019

GlobeNewswire 2/19/2019 Welcome to the Annual General Meeting in Skandinaviska Enskilda Banken AB on 26 March 2019

GlobeNewswire 2/5/2019 SEB: Investment Outlook: Slowing growth rate, but more attractive asset valuations

GlobeNewswire 2/4/2019 Changes to Nomination Committee for SEB